Highlight of FDA approvals 2016: Venetoclax

Editor

8 years ago

In this presentation from Lymphoma & Myeloma 2016, Dr. Richard R. Furman discusses the recent FDA approval of venetoclax for the treatment of chronic lymphocytic leukemia (CLL).

Click to Earn CME Credit: http://bit.ly/2lDPthL